key: cord-0899467-1fkihayk authors: Amit Jadhav, Siddhita; Biji, Pullithadathil.; Kumar Panthalingal, Manoj; Murali, Chilakapati; Kulkarni, Anjali; Rajkumar, Sankaranarayanan; Joshi, Dattatraya S.; Natarajan, Sundaram title: Development of Integrated Microfluidic Platform Coupled with Surface-Enhanced Raman Spectroscopy for Diagnosis of COVID-19 date: 2020-11-17 journal: Med Hypotheses DOI: 10.1016/j.mehy.2020.110356 sha: 86957bcc803d100af2ca3b443b317b4d947304ae doc_id: 899467 cord_uid: 1fkihayk Corona Virus Disease 19 (COVID-19) pandemic has created an alarming situation across the globe. Varieties of diagnostic protocols are being developed for the diagnosis of COVID-19. Many of these diagnostic protocols however, have limitations such as for example unacceptable no of false-positive and false-negative cases, particularly during the early stages of infection. At present, the real-time (quantitative) reverse transcriptase-polymerase chain reaction (RT-PCR) is considered the gold standard for COVID-19 diagnosis. However, RT-PCR based tests are complex, expensive, time consuming and involve pre-processing of samples. A swift, sensitive, inexpensive protocol for mass screening is urgently needed to contain this pandemic. There is urgent need to harness new powerful technologies for accurate detection not only of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) but also combating the emergence of pandemics of new viruses as well. To overcome the current challenges, the authors propose a diagnostic protocol based on surface-enhanced Raman Spectroscopy (SERS) coupled with microfluidic devices containing integrated microchannels functionalized either with vertically aligned Au/Ag coated carbon nanotubes or with disposable electrospun micro/nano-filter membranes. These devices have the potential to successfully trap viruses from diverse biological fluids/secretions including saliva, nasopharyngeal, tear etc. These can thus enrich the viral titre and enable accurate identification of the viruses from their respective Raman signatures. If the device is successfully developed and proven to detect target viruses, it would facilitate rapid screening of symptomatic as well as asymptomatic individuals of COVID-19. This would be a valuable diagnostic tool not only for mass screening of current COVID -19 pandemic but also in viral pandemic outbreaks of future. To the best of our knowledge, this will be the first and a novel approach to develop a which will be an essential step in preventing the silent spread of the virus. The aim is to develop the prototype which facilitates size dependent trapping of SARS-CoV-191 future. Therefore, the authors propose to use two models; one with gold and another one with 206 silver nanoparticles as plasmonic material. Proposed Prototype The two following proposed models are based on the unique concept of SERS coupled with 211 microfluidic device for the detection of COVID-19 from biological fluids. Model 1 A cost-effective Polydimethylsiloxane (PDMS) based microfluidic device with integrated 216 disposable type micro/nanofilter and SERS strips is proposed for rapid screening of 217 asymptomatic COVID-19 patients. Figure 1 depicts the basic design of disposable type 218 PDMS microfluidic device. In the microfluidic platform, the microchannels will be integrated 219 with disposable electrospun micro/nano-filter membrane and the detection well can be 220 functionalized with a disposable Ag functionalized cellulose paper based SERS strip. The 221 overall PDMS microfluidic device will be fabricated using 3D printing process to facilitate 222 batch production. Initial trials will be tested using simulated body fluids. It is believed that this technique could provide a viable, long term alternative for reliable 258 diagnosis of SARS-CoV-2 identity. Importantly, positive outcome of any of these two 259 prototypes will facilitate design and manufacture of versatile, portable platforms to contain 260 future outbreak of viral epidemic with steep reduction in the response time. Validation of the prototypes is needed in the initial stage in determining the specificity and 265 sensitivity of the proposed prototypes as against gold standard methods such as RT-PCR. The authors of the study jointly proposed this diagnostic tool for the detection of SARS-CoV, 279 and are planning to submit this concept as a multicentric proposal for seeking research grant Genotype and phenotype of COVID-19: Their roles in 323 pathogenesis Recent trends SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Assay 333 Techniques and Test Development for COVID-19 Diagnosis Tunable 341 and label-free virus enrichment for ultrasensitive virus detection using carbon 342 nanotube arrays A rapid and 346 label-free platform for virus capture and identification from clinical samples Evaluation of coronavirus in tears and 362 conjunctival secretions of patients with SARS-CoV-2 infection 366 replication competence, and innate immune responses of the coronavirus SARS-CoV-367 2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro 368 cultures ACE2 and 372 TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to 373 SARS-CoV-2 infection Spectroscopy Based Detection of RNA viruses in Saliva: a preliminary report Manuscript title: Development of Integrated Microfluidic Platform coupled with surface enhanced Raman 387 Institute of Advanced Studies, Post Box No1609 Tamilnadu 410 8. PSG Institute of Technology and Applied Research Advanced Centre for Treatment Research and Education in Cancer (ACTREC) Tata Maharashtra 414 10. Medical Division, Bhabha Atomic Research Centre